The LUVEN screening test method created by scientist of our company detects cancer at its early stages with the accuracy of up to 96% only comparable to biopsy. None of the existing diagnostic techniques has such a high diagnostic accuracy. The LUVEN technology allows diagnosing the disease at its early stages , thus, giving a chance to thousands of people to prevent its further development.

Team

  • Name
  • Position
  • Links
  • Alexander Danilchenko
  • CEO
  • Nikolay Shchukin
  • Postgraduate Student of Chair for Biomedical Engineering
  • Aleksander Shchukin
  • Nuclear Physician
  • Galina Shchukina
  • Geneticist & Cytologist
  • Grigory Evglevskiy
  • CTO
  • Alexander Kamensky
  • Principal Software Engineer
  • Yana Ivchenko
  • PR Manager
Trade Token on Bitcratic
Status

Ended

Token LVN
PreICO Price 290 LVN = 1 ETH
Price 290 LVN = 1 ETH
BonusAvailable
Platform Ethereum
Accepting ETH, BTC
Minimum investment 0.1 ETH
Country Ukraine
Category Drugs & Healthcare
Total Supply 30,000,000
Latest News

Leave a Reply

Your email address will not be published. Required fields are marked *